What Trump’s ‘Great Healthcare Plan’ means for drug costs and price transparency

Published 5 Min Read

Adobe Stock

  • Key Insight: Here’s why Trump’s proposed “Great Healthcare Plan” redirects federal subsidies directly to eligible Americans.
  • What’s at Stake: Employers and employees facing rising premiums from complex pharmacy benefit manager financial arrangements.
  • Expert Quote: “Transparency should be operational, not theoretical.” — Kristin Begley, COO, Judi Health
    Source: Bullets generated by AI with editorial review.

A new healthcare proposal from President Trump has the potential to lower drug costs and increase price transparency — and leaders will have an important part to play

Paola Peralta
Associate Editor

Paola Peralta is an Associate Editor at Employee Benefit News and has been with the team for five years. She is a proud UCF journalism graduate who got her start through a Dow Jones News Fund … Read full bio


For reprint and licensing requests for this article, click here.


More From Employee Benefit News

Sign Up Form

Login Modal Form